Estrogen regulates Hippo signaling via GPER in breast cancer
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
The G protein-coupled estrogen receptor (GPER) mediates both the genomic and nongenomic effects of estrogen and has been implicated in breast cancer development. Here, we compared GPER expression in cancerous tissue and adjacent normal tissue in patients with invasive ductal carcinoma (IDC) of the breast and determined that GPER is highly upregulated in cancerous cells. Additionally, our studies revealed that GPER stimulation activates yes-associated protein 1 (YAP) and transcriptional coactivator with a PDZ-binding domain (TAZ), 2 homologous transcription coactivators and key effectors of the Hippo tumor suppressor pathway, via the Gαq-11, PLCβ/PKC, and Rho/ROCK signaling pathways. TAZ was required for GPER-induced gene transcription, breast cancer cell proliferation and migration, and tumor growth. Moreover, TAZ expression positively correlated with GPER expression in human IDC specimens. Together, our results suggest that the Hippo/YAP/TAZ pathway is a key downstream signaling branch of GPER and plays a critical role in breast tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Emerging evidence suggests that dysregulation of the Hippo-YAP/TAZ pathway is a central resistance mechanism in various tumors to multiple targeted therapies, chemotherapies, hormonal therapies, and immunotherapies (23–27).”
From YAP/TAZ mediates resistance to KRAS inhibitors through inhibiting proapoptosis and activating the SLC7A5/mTOR axis (2024) · cites this paper as [27]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of YAP/TAZ in mechanotransduction
Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979
Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092
Self-citationTEAD mediates YAP-dependent gene induction and growth control
Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M., et al. (2008) · Genes & Development · doi:10.1101/gad.1664408 · Cited by 2,498
Self-citationElucidation of a universal size-control mechanism in Drosophila and mammals
Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A., & Pan, D. (2007) · Cell · doi:10.1016/j.cell.2007.07.019 · Cited by 2,370
A transmembrane intracellular estrogen receptor mediates rapid cell signaling
Revankar, C. M., Cimino, D. F., Sklar, L. A., Arterburn, J. B., & Prossnitz, E. R. (2005) · Science · doi:10.1126/science.1106943 · Cited by 2,302 · cited 2×
“Rapid mobilization of intracellular calcium, which is widely observed upon GPER stimulation (4, 36), is a representative phenomenon of activation of phospholipase Cβ (PLCβ) signaling, which is directly controlled by the specific G protein Gαq/11 (5, 38).”
BackgroundThe Hippo pathway and human cancer
Harvey, K. F., Zhang, X., & Thomas, D. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3458 · Cited by 1,842
Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
Yu, F.-X., Zhao, B., Panupinthu, N., Jewell, J. L., Lian, I., Wang, L. H., Zhao, J., Yuan, H., Tumaneng, K., Li, H., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.037 · Cited by 1,628
Self-citationA coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF β-TRCP
Zhao, B., Li, L., Tumaneng, K., Wang, C.-Y., & Guan, K.-L. (2010) · Genes & Development · doi:10.1101/gad.1843810 · Cited by 1,418
Self-citationIdentity of an Estrogen Membrane Receptor Coupled to a G Protein in Human Breast Cancer Cells
Thomas, P., Pang, Y., Filardo, E. J., & Dong, J. (2005) · Endocrinology · doi:10.1210/en.2004-1064 · Cited by 1,407
Research works printed but not linked: 1
- 10.1210/mend.14.10.0532 · DOI · Paper page
Cited by
Hippo pathway in organ size control, tissue homeostasis, and cancer
Yu, F.-X., Zhao, B., & Guan, K.-L. (2015) · Cell · doi:10.1016/j.cell.2015.10.044 · Cited by 2,206
Self-citationMechanisms of Hippo pathway regulation
Meng, Z., Moroishi, T., & Guan, K.-L. (2016) · Genes & Development · doi:10.1101/gad.274027.115 · Cited by 1,667
Self-citationThe Hippo Pathway: Biology and Pathophysiology
Ma, S., Meng, Z., Chen, R., & Guan, K.-L. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-013118-111829 · Cited by 1,387
“Specifically, ligand signaling through GPCRs coupled to Gα12/13, Gαi/o, or Gαq/11, such as LPA, thrombin, angiotensin II, and estrogen, activates YAP/TAZ; in contrast, ligand signaling through GPCRs coupled to Gαs, such as glucagon and epinephrine, suppresses YAP/TAZ activity (93, 124).”
BackgroundSelf-citationThe Hippo signalling pathway and its implications in human health and diseases
Fu, M., Hu, Y., Lan, T., Guan, K.-L., Luo, T., & Luo, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01191-9 · Cited by 742
Self-citationInterplay between YAP/TAZ and Metabolism
Koo, J. H., & Guan, K.-L. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.010 · Cited by 472
Self-citationHippo Signaling in Embryogenesis and Development
Wu, Z., & Guan, K.-L. (2021) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.08.008 · Cited by 234
Self-citationThe G protein-coupled oestrogen receptor GPER in health and disease: an update
Prossnitz, E. R., & Barton, M. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00822-7 · Cited by 231
Breast Cancer: A Molecularly Heterogenous Disease Needing Subtype-Specific Treatments
Testa, U., Castelli, G., & Pelosi, E. (2020) · Medical Sciences · doi:10.3390/medsci8010018 · Cited by 214
Song, S., Xie, M., Scott, A. W., Jin, J., Ma, L., Dong, X., Skinner, H. D., Johnson, R. L., Ding, S., & Ajani, J. A. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0560 · Cited by 196
The Role of Hippo Pathway in Cancer Stem Cell Biology.
Park, J. H., Shin, J. E., & Park, H. W. (2018) · PubMed · doi:10.14348/molcells.2018.2242 · Cited by 193
Lnc RNA wires up Hippo and Hedgehog signaling to reprogramme glucose metabolism
Zheng, X., Han, H., Liu, G., Ma, Y., Pan, R., Sang, L., Li, R., Yang, L., Marks, J. R., Wang, W., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201797609 · Cited by 191
Glucocorticoid receptor signalling activates YAP in breast cancer
Sorrentino, G., Ruggeri, N., Zannini, A., Ingallina, E., Bertolio, R., Marotta, C., Neri, C., Cappuzzello, E., Forcato, M., Rosato, A., et al. (2017) · Nature Communications · doi:10.1038/ncomms14073 · Cited by 176
Chen, Y.-A., Lu, C.-Y., Cheng, T., Pan, S., Chen, H., & Chang, N. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00060 · Cited by 177
Li, R.-H., Tian, T., Ge, Q.-W., He, X.-Y., Shi, C.-Y., Li, J.-H., Zhang, Z., Liu, F.-Z., Sang, L.-J., Yang, Z.-Z., et al. (2021) · Cell Research · doi:10.1038/s41422-021-00530-9 · Cited by 173
Self-citationTargeting YAP1/LINC00152/FSCN1 Signaling Axis Prevents the Progression of Colorectal Cancer
Ou, C., Sun, Z., He, X., Li, X., Fan, S., Zheng, X., Qiu, P., Li, G., Li, X., & Ma, J. (2019) · Advanced Science · doi:10.1002/advs.201901380 · Cited by 170
YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance
Szulzewsky, F., Holland, E. C., & Vasioukhin, V. I. (2021) · Developmental Biology · doi:10.1016/j.ydbio.2020.12.018 · Cited by 167
The Hippo pathway in normal development and cancer
Maugeri-Saccà, M., & De Maria, R. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.12.011 · Cited by 167
YAP/TAZ Activation as a Target for Treating Metastatic Cancer
Warren, J., Xiao, Y., & Lamar, J. (2018) · Cancers · doi:10.3390/cancers10040115 · Cited by 164
Wang, S., Su, X., Xu, M., Xiao, X., Li, X., Li, H., Keating, A., & Zhao, R. C. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1220-2 · Cited by 164
Self-citationThe role of sex hormones and steroid receptors on female reproductive cancers
Chuffa, L. G. D. A., Lupi, L. A., Costa, A. B., Amorim, J. P. D. A., & Seiva, F. R. F. (2016) · Steroids · doi:10.1016/j.steroids.2016.12.011 · Cited by 159
Sun, M., Song, H., Wang, S., Zhang, C., Zheng, L., Chen, F., Shi, D., Chen, Y., Yang, C., Xiang, Z., et al. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0445-8 · Cited by 155
Self-citationCrosstalk between Notch, HIF-1α and GPER in Breast Cancer EMT
De Francesco, E. M., Maggiolini, M., & Musti, A. M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072011 · Cited by 142
GPCR-Hippo Signaling in Cancer
Luo, J., & Yu, F. (2019) · Cells · doi:10.3390/cells8050426 · Cited by 130
Self-citationIijima, H., Gilmer, G. G., Wang, K., Bean, A., He, Y., Lin, H., Tang, W., Lamont, D. N., Tai, C., Ito, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35359-2 · Cited by 126
Feng, X., Liu, P., Zhou, X., Li, M.-T., Li, F.-L., Wang, Z., Meng, Z., Sun, Y.-P., Yu, Y., Xiong, Y., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.739722 · Cited by 119
Self-citationOu, C., Sun, Z., Li, X., Li, X., Ren, W., Qin, Z., Zhang, X., Yuan, W., Wang, J., Yu, W., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.04.011 · Cited by 116
Molina, L., Figueroa, C. D., Bhoola, K. D., & Ehrenfeld, P. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1350264 · Cited by 114
Steroid Hormones, Steroid Receptors, and Breast Cancer Stem Cells
Finlay-Schultz, J., & Sartorius, C. A. (2015) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-015-9340-5 · Cited by 111
Feldman, R. D., & Limbird, L. E. (2017) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104651 · Cited by 108
G Protein-Coupled Estrogen Receptor: A Potential Therapeutic Target in Cancer
Xu, S., Yu, S., Dong, D., & Lee, L. T. O. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00725 · Cited by 107
Multifaceted regulation and functions of YAP/TAZ in tumors (Review)
Liu, H., Du, S., Lei, T., Wang, H., He, X., Tong, R., & Wang, Y. (2018) · Oncology Reports · doi:10.3892/or.2018.6423 · Cited by 105
G-Protein Coupled Estrogen Receptor in Breast Cancer
Hsu, L.-H., Chu, N.-M., Lin, Y.-F., & Kao, S.-H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020306 · Cited by 102
Mediated nuclear import and export of TAZ and the underlying molecular requirements
Kofler, M., Speight, P., Little, D., Di Ciano-Oliveira, C., Szászi, K., & Kapus, A. (2018) · Nature Communications · doi:10.1038/s41467-018-07450-0 · Cited by 100
YAP and TAZ Take Center Stage in Cancer
Zhang, K., Qi, H.-X., Hu, Z., Chang, Y., Shi, Z., Han, X., Han, Y., Zhang, R., Zhang, Z., Chen, T., et al. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b01014 · Cited by 100
The oncogenic roles and clinical implications of YAP/TAZ in breast cancer
Luo, J., Zou, H., Guo, Y., Tong, T., Chen, Y., Xiao, Y., Pan, Y., & Li, P. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02182-5 · Cited by 97
Nogués, L., Palacios‐García, J., Reglero, C., Rivas, V., Neves, M., Ribas, C., Penela, P., & Mayor, F. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.04.013 · Cited by 96
The Hippo signaling pathway provides novel anti-cancer drug targets
Bae, J. S., Kim, S. M., & Lee, H. (2016) · Oncotarget · doi:10.18632/oncotarget.14306 · Cited by 97
Rigiracciolo, D. C., Nohata, N., Lappano, R., Cirillo, F., Talia, M., Scordamaglia, D., Gutkind, J. S., & Maggiolini, M. (2020) · Cells · doi:10.3390/cells9041010 · Cited by 94
Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
Girgert, R., Emons, G., & Gründker, C. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00781 · Cited by 89
The role of Hippo signal pathway in breast cancer metastasis
Wei, C., Wang, Y., & Li, X. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s157058 · Cited by 89
Advanced Role of Hippo Signaling in Endometrial Fibrosis: Implications for Intrauterine Adhesion
Zhu, H.-Y., Ge, T., Pan, Y., & Zhang, S. (2017) · Chinese Medical Journal · doi:10.4103/0366-6999.218013 · Cited by 88
Self-citationHarmine induces anticancer activity in breast cancer cells via targeting TAZ
Ding, Y., He, J., Huang, J., Yu, T., Shi, X., Zhang, T., Ge, Y., Chen, S., & Peng, C. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4777 · Cited by 88
Endothelin Promotes Colorectal Tumorigenesis by Activating YAP/TAZ
Wang, Z., Liu, P., Zhou, X., Wang, T., Feng, X., Sun, Y.-P., Xiong, Y., Yuan, H.-X., & Guan, K. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3229 · Cited by 86
Self-citationDeng, Q., Jiang, G., Wu, Y., Li, J., Liang, W., Chen, L., Su, Q., Li, W., Du, J., Wong, C. K. C., et al. (2018) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2018.05.013 · Cited by 85
Regulation of the Hippo pathway in cancer biology
Moon, S., Park, S. Y., & Park, H. W. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2804-1 · Cited by 85
Wang, H., Lu, B., Cabrera, J. C., Zhang, Y., Yang, Z., McAllister, G., Lindeman, A., Reece-Hoyes, J. S., Tallarico, J. A., Russ, C., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.722967 · Cited by 82
The role of Hippo‐YAP signaling in squamous cell carcinomas
Maehama, T., Nishio, M., Otani, J., Mak, T. W., & Suzuki, A. (2020) · Cancer Science · doi:10.1111/cas.14725 · Cited by 81
The G protein-coupled estrogen receptor as a modulator of neoplastic transformation
Jacenik, D., Cygankiewicz, A. I., & Krajewska, W. M. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.04.011 · Cited by 80
Shen, Y., Li, C., Zhou, L. M., & Huang, J. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15997 · Cited by 80
Recent Advances of the Hippo/YAP Signaling Pathway in Brain Development and Glioma
Ouyang, T., Meng, W., Li, M., Hong, T., & Zhang, N. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00762-9 · Cited by 80
Role of cytoplasmic lncRNAs in regulating cancer signaling pathways
Fu, P., Zheng, X. M., Xiao, F., & Lin, A. (2019) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1800254 · Cited by 73
Liu, Q., Liu, Y., Li, X., Wang, D., Zhang, A., Pang, J., He, J., Chen, X., & Tang, N. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.114980 · Cited by 68
Gelsomino, L., Panza, S., Giordano, C., Barone, I., Gu, G., Spina, E. L., Catalano, S., Fuqua, S. A. W., & Andò, S. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.04.023 · Cited by 67
Melatonin Protects against Lung Fibrosis by Regulating the Hippo/YAP Pathway
Zhao, X., Sun, J., Su, W., Shan, H., Zhang, B., Wang, Y., Shabanova, A., Shan, H., & Liang, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041118 · Cited by 64
Filardo, E. J. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.05.005 · Cited by 63
Molecular Characterization of Membrane Steroid Receptors in Hormone-Sensitive Cancers
Masi, M., Racchi, M., Travelli, C., Corsini, E., & Buoso, E. (2021) · Cells · doi:10.3390/cells10112999 · Cited by 62
Wang, J., Shidfar, A., Ivancic, D., Ranjan, M., Liu, L., Choi, M.-R., Parimi, V., Gursel, D. B., Sullivan, M. E., Najor, M. S., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30680 · Cited by 61
Echinacoside inhibits breast cancer cells by suppressing the Wnt/β-catenin signaling pathway
Tang, C., Gong, L., Xu, L., Qiu, K., Zhang, Z., & Wan, L. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.03.050 · Cited by 59
Nucleo-cytoplasmic transport of estrogen receptor alpha in breast cancer cells
Tecalco-Cruz, Á. C., Pérez-Alvarado, I. A., Ramírez‐Jarquín, J. O., & Rocha‐Zavaleta, L. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.03.011 · Cited by 59
YAP and endothelin-1 signaling: an emerging alliance in cancer
Tocci, P., Blandino, G., & Bagnato, A. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01827-8 · Cited by 58
Sileo, P., Simonin, C., Melnyk, P., Chartier‐Harlin, M., & Cotelle, P. (2022) · Cells · doi:10.3390/cells11223631 · Cited by 57
Zhou, X., & Lei, Q. (2016) · Protein & Cell · doi:10.1007/s13238-016-0288-z · Cited by 57
Self-citationRegulation of Tissue Growth by the Mammalian Hippo Signaling Pathway
Watt, K. I., Harvey, K. F., & Gregorevic, P. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00942 · Cited by 57
Wu, P., Hou, X., Miao, P., Deng, X., Yan, Q., Fan, C., Mo, Y., Wang, Y., Li, Z., Wang, F., et al. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01171-8 · Cited by 56
Liang, H., Liu, S., Chen, Y., Bai, X., Liu, L., Dong, Y., Hu, M., Su, X., Chen, Y., Huangfu, L., et al. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1381-8 · Cited by 54
Molina, L., Bustamante, F. A., Ortloff, A., Ramos, I., Ehrenfeld, P., & Figueroa, C. D. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.563165 · Cited by 53
LncRNAs divide and rule: The master regulators of phase separation
Somasundaram, K., Gupta, B., Jain, N., & Jana, S. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.930792 · Cited by 52
O-GlcNAcylation regulation of cellular signaling in cancer
Ciraku, L., Esquea, E. M., & Reginato, M. J. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110201 · Cited by 52
Stevenson, B., Doorley, J., Moddeman, G. R., & Benson-Landau, M. (1995) · PubMed · Cited by 51
Lo, E. K. K., Lee, J. C., Turner, P. C., & El-Nezami, H. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-86788-w · Cited by 48
Talia, M., Francesco, E. M. D., Rigiracciolo, D. C., Muoio, M. G., Muglia, L., Belfiore, A., Maggiolini, M., Sims, A. H., & Lappano, R. (2020) · Cells · doi:10.3390/cells9030622 · Cited by 48
Emerging role of Hippo signalling pathway in bladder cancer
Xia, J., Zeng, M., Zhu, H., Chen, X., Weng, Z., & Li, S. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13293 · Cited by 47
Self-citationCheng, J., Fang, L., Li, Y., Thakur, A., Hoodless, P. A., Guo, Y., Wang, Z., Wu, Z., Yan, Y., Jia, Q., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02816-5 · Cited by 47
Self-citationEstrogen Activation by Steroid Sulfatase Increases Colorectal Cancer Proliferation via GPER
Gilligan, L. C., Rahman, H. P., Hewitt, A.-M., Sitch, A. J., Gondal, A., Arvaniti, A., Taylor, A. E., Read, M. L., Morton, D. G., & Foster, P. A. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3716 · Cited by 46
Research progress on the antitumor effects of harmine
Hu, Y., Yu, X., Yang, L., Xue, G., Wei, Q., Han, Z., & Chen, H. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1382142 · Cited by 45
The Hippo transducers TAZ/YAP and their target CTGF in male breast cancer
Benedetto, A. D., Mottolese, M., Sperati, F., Ercolani, C., Lauro, L. D., Pizzuti, L., Vici, P., Terrenato, I., Sperduti, I., Shaaban, A. M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9668 · Cited by 44
Li, M., Rao, X., Cui, Y., Zhang, L., Li, X., Wang, B., Zheng, Y., Teng, L., Zhou, T., & Zhuo, W. (2021) · Oncogene · doi:10.1038/s41388-021-02119-3 · Cited by 43
Vella, V., Francesco, E. M. D., Lappano, R., Muoio, M. G., Manzella, L., Maggiolini, M., & Belfiore, A. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.608412 · Cited by 43
Kim, H., Son, S., Ko, Y., Lee, J. E., Kim, S., & Shin, I. (2021) · Journal of Cell Science · doi:10.1242/jcs.256503 · Cited by 42
Hippo pathway contributes to cisplatin resistant-induced EMT in nasopharyngeal carcinoma cells
Li, S., Zhang, X., Zhang, R., Liang, Z., Liao, W., Du, Z., Gao, C., Liu, F., Fan, Y., & Hong, H. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1356508 · Cited by 42
Wang, Z., Sun, L., Liang, S. A., Liu, Z.-C., Zhao, Z.-Y., Yang, J., Wang, D., & Yang, D. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.06.132 · Cited by 42
Self-citationPerspectives of Reprogramming Breast Cancer Metabolism
Wang, Y.-P., & Lei, Q. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-6020-5_10 · Cited by 41
Self-citationSadri, F., Hosseini, S. F., Rezaei, Z., & Fereidouni, M. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.01.017 · Cited by 39
The role of extracellular biophysical cues in modulating the Hippo-YAP pathway
Mo, J. (2017) · BMB Reports · doi:10.5483/bmbrep.2017.50.2.199 · Cited by 39
Breast cancer stem cells: the role of sex steroid receptors
Giovannelli, P., Donato, M. D., Galasso, G., Zazzo, E. D., Medici, N., Bilancio, A., Migliaccio, A., & Castoria, G. (2019) · World Journal of Stem Cells · doi:10.4252/wjsc.v11.i9.594 · Cited by 39
Zhuang, Q., Li, F., Liu, J., Wang, H., Tian, Y., Zhang, Z., Wang, F., Zhao, Z., Chen, J., & Wu, H. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-00503-3 · Cited by 39
Self-citationTian, S., Zhan, N., Li, R., & Dong, W. (2019) · Medical Science Monitor · doi:10.12659/msm.913634 · Cited by 38
Hippo Cascade Controls Lineage Commitment of Liver Tumors in Mice and Humans
Zhang, S., Wang, J., Wang, H., Fan, L., Fan, B., Zeng, B., Tao, J., Li, X., Che, L., Cigliano, A., et al. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.12.017 · Cited by 37
G protein‐coupled receptors can control the Hippo/YAP pathway through Gq signaling
Zindel, D., Mensat, P., Vol, C., Homayed, Z., Charrier‐Savournin, F., Trinquet, E., Banères, J., Pin, J., Pannequin, J., Roux, T., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202002159r · Cited by 37
Shen, Y., Yang, F., Zhang, W., Song, W., Liu, Y., & Guan, X. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000484187 · Cited by 37
MRTF/SRF dependent transcriptional regulation of TAZ in breast cancer cells
Liu, C.-Y., Chan, S. W., Guo, F., Toloczko, A., Cui, L., & Hong, W. (2016) · Oncotarget · doi:10.18632/oncotarget.7333 · Cited by 36
Konings, G. F. J., Reynaert, N. L., Delvoux, B., Verhamme, F. M., Bracke, K. R., Brusselle, G., Romano, A., & Vernooy, J. H. J. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.12.001 · Cited by 36
Role of Hedgehog and Hippo signaling pathways in cancer: A special focus on non-coding RNAs
Sharma, U., Tuli, H. S., Uttam, V., Choudhary, R., Sharma, B., Sharma, U., Prakash, H., & Jain, A. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106523 · Cited by 36
Lu, A. S., Rouhimoghadam, M., Arnatt, C. K., Filardo, E. J., & Salem, A. K. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00018 · Cited by 35
Qin, X., Luo, H., Deng, Y., Yao, X., Zhang, J., & He, B. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.10.077 · Cited by 35
Kyriazoglou, A. I., Liontos, M., Zakopoulou, R., Kaparelou, M., Tsiara, A., Papatheodoridi, A. M., Georgakopoulou, R., & Zagouri, F. (2020) · Breast Care · doi:10.1159/000507538 · Cited by 34
SASH1 suppresses triple-negative breast cancer cell invasion through YAP-ARHGAP42-actin axis
Jiang, K., Liu, P., Xu, H., Liang, D., Fang, K., Du, S., Cheng, W., Ye, L., Liu, T., Zhang, X., et al. (2020) · Oncogene · doi:10.1038/s41388-020-1356-7 · Cited by 34
Self-citationEndogenous YAP1 activation drives immediate onset of cervical carcinoma in situ in mice
Nishio, M., To, Y., Maehama, T., Aono, Y., Otani, J., Hikasa, H., Kitagawa, A., Mimori, K., Sasaki, T., Nishina, H., et al. (2020) · Cancer Science · doi:10.1111/cas.14581 · Cited by 34
Disease implication of hyper-Hippo signalling
Wang, S., & Wang, L.-H. (2016) · Open Biology · doi:10.1098/rsob.160119 · Cited by 33
Self-citationYang, W., Zhang, M., Zhang, T.-X., Liu, J.-H., Hao, M.-W., Yan, X., Gao, H., Lei, Q.-Y., Cui, J., & Zhou, X. (2024) · JCI Insight · doi:10.1172/jci.insight.178535 · Cited by 31
“Emerging evidence suggests that dysregulation of the Hippo-YAP/TAZ pathway is a central resistance mechanism in various tumors to multiple targeted therapies, chemotherapies, hormonal therapies, and immunotherapies (23–27).”
Self-citation
Metadata
- Authors
- Zhou, X., Wang, S., Wang, Z., Feng, X., Liu, P., Lv, X.-B., Li, F., Yu, F.-X., Sun, Y., Yuan, H., Zhu, H., Xiong, Y., Lei, Q.-Y., & Guan, K.-L.
- Affiliations
- Shanghai Medical College of Fudan University (CN)
- Fudan University (CN)
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Zhou, Xin
- Wang, Shuyang
- Xiong, Yue
- Lei, Qun-Ying
- Guan, Kun-Liang
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2015-04-20
- Volume
- 125
- Issue
- 5
- Pages
- 2123-2135
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC4463207
- OpenAlex
- W2008439293
- Cited by
- 232
- References
- 50
- Citations by year
- 2026: 19 · 2025: 14 · 2024: 14 · 2023: 20 · 2022: 22 · 2021: 25 · 2020: 32 · 2019: 17 · 2018: 21 · 2017: 27 · 2016: 15 · 2015: 4
- FWCI
- 11.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- UNC Libraries
- Funders
- Shanghai Key Basic Research Program
- National Natural Science Foundation of China (81430057, 2012CB910101, 31271454, 81225016)
- Ministry of Science and Technology of the People's Republic of China (2012CB910101, 2011CB910601, 2015CB910401)
- Fudan University
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- G protein-coupled estrogen receptor, Hippo signaling pathway, YAP, TAZ, breast cancer, invasive ductal carcinoma, Gαq/11, Rho/ROCK signaling, tumor growth, cell proliferation, cell migration
- MeSH terms
- Hippo Signaling Pathway, Serine-Threonine Kinase 3, YAP-Signaling Proteins, Hippo Kinases, Acyltransferases, Animals, Breast Neoplasms, Cell Division, Cell Movement, Cell Transformation, Neoplastic, Estrogens, Female, Humans, Mice, Inbred BALB C, Neoplasm Proteins, Neoplasms, Hormone-Dependent, Phosphoproteins, Phosphorylation, Protein Kinase C, Protein Processing, Post-Translational, Receptors, Estrogen, Transcription Factors, Transcription, Genetic, Signal Transduction, Gene Expression Regulation, Neoplastic, Protein Serine-Threonine Kinases, Carcinoma, Ductal, Breast, Tumor Suppressor Proteins, RNA Interference, Receptors, G-Protein-Coupled, GTP-Binding Protein alpha Subunits, Gq-G11, Intracellular Signaling Peptides and Proteins, Adaptor Proteins, Signal Transducing, Mice, rho-Associated Kinases, Phospholipase C beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.